CytoMed Therapeutics Limited
GDTC
Last
$0.89
Day
-5.8%
1y
-55.2%
5y
-76.4%
52w
-74.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
0.92
EMA 50
0.92
EMA 200
1.13
20d high
-10.9%
5y high
-89.8%
5y range
3th
Positions held
Your positionsGDTC isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
6
Hold
watch
Signal
Neutral
Target
$1.14
Stop
$0.79
Stop distance
11.2%
Target vs last
+28.1%
Fundamentals
| Market cap | $11.28M | Enterprise value | $10.70M | Trailing P/E | — | Forward P/E | -6.30 |
| PEG | — | Price / book | 2.90 | Beta | 0.07 | Dividend yield | 0.00% |
| Revenue growth | -15.9% | Earnings growth | — | Gross margin | 85.9% | Operating margin | -4.8% |
| Profit margin | 0.0% | ROE | -56.2% | ROA | -32.5% | Debt / equity | 0.08 |
| Current ratio | 2.64 | Free cash flow | -$2.37M | Analyst recommendation | none | Mean target | $4.16 |
| 52w high | $3.68 | 52w low | $0.68 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.3M | $0.1M | $0.0M | $0.0M | — |
| Op margin | -1307.6% | -4504.3% | — | — | — |
| Net income | -$4.0M | -$2.5M | -$4.1M | -$3.1M | — |
| Gross margin | 79.0% | 75.4% | — | — | — |
| Gross profit | $0.3M | $0.1M | $0.0M | $0.0M | — |
| Operating income | -$4.2M | -$3.1M | -$3.8M | -$1.9M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsGDTC · daily+3.8% over 13 sessions
Close EMA21 EMA50 EMA200